The inhibitory or activating effect of the cGAS-stimulator of interferon genes (STING) pathway plays a vital role in the occurrence and development of non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), viral hepatitis, liver fibrosis, liver cancer and other liver diseases. This evidence concerns the gene STING1 and animal viral hepatitis.